Procurement of drugs only from legitimate sources

Ask AI

BFAD FDA MEMORANDUM CIRCULAR 001 s. 1983: Procurement of drugs only from legitimate sources

Getting related questions...
What do you want to know about the law?
Your conversations and searches stay on your device. We do not store or track your activity on our servers. To know more about our privacy commitment see jur.ph/privacy Ask AI provides quick answers grounded in full case texts to avoid mistakes. Always verify with the original text.

Ask AI

Title Supreme Court: Procurement of drugs only from legitimate sources

Law: Bfad Fda Memorandum Circular 001 S. 1983

Decision Date: Mar 10, 1983

Retailers are mandated to source drugs exclusively from authorized distributors, with strict penalties for non-compliance, to combat the distribution of substandard medications.

drug regulation

A

Documentation Requirements for Drug Transactions

Every purchase transaction involving drugs and medicines must be properly documented with a sales invoice.
The sales invoice must include critical details such as the lot or batch number from the manufacturer’s stock.

Consequences of Procuring from Unauthorized Sources

Stocks obtained from illegitimate or unauthorized sources are considered violative and not approved by the Food and Drug Administration (FDA).
Such stocks are subject to immediate seizure or confiscation as prescribed by LOI No. 1223 dated April 12, 1982.

Enforcement and Penalties

The FDA is empowered to undertake further administrative and legal actions against violations.
Possible actions include the prosecution of the owner, pharmacist, and other parties involved.
The closure of the drug establishment may also be enforced as a penalty.

Authority and Implementation

The directive is issued to ensure strict compliance by all concerned parties in the drug retail sector.
Issued initially in 1983 and reissued in 1991 to reaffirm the commitment to drug safety and regulatory compliance under FDA supervision.

END